4/16
12:18 pm
dmac
DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference [Yahoo! Finance]
3/31
03:09 pm
dmac
DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
3/31
10:57 am
dmac
DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/31
09:44 am
dmac
DiaMedica Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
DiaMedica Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
3/30
05:20 pm
dmac
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
3/30
04:57 pm
dmac
DiaMedica Therapeutics GAAP EPS of -$0.70 misses by $0.02 [Seeking Alpha]
Low
Report
DiaMedica Therapeutics GAAP EPS of -$0.70 misses by $0.02 [Seeking Alpha]
3/30
04:45 pm
dmac
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
Low
Report
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
3/23
08:25 am
dmac
DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
Medium
Report
DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
3/5
07:57 am
dmac
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia [Yahoo! Finance]
3/5
07:35 am
dmac
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
Low
Report
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
3/2
01:14 pm
dmac
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight [Yahoo! Finance]
Low
Report
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight [Yahoo! Finance]
2/24
09:49 am
dmac
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/24
09:23 am
dmac
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
Neutral
Report
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
1/16
05:00 pm
dmac
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)